This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Terence M Doherty: Innovator in Pulmonary Artery Hypertension Treatment
Introduction
Terence M Doherty is a notable inventor based in Corona, California. He has made significant contributions to the field of biomedical innovation, particularly in the treatment of heritable pulmonary artery hypertension.
Latest Patents
Doherty holds a patent for a composition and methods aimed at treating heritable pulmonary artery hypertension associated with nonsense mutations. The patent details a method that involves administering a compound, such as GJ103 and its salts, to subjects in need of treatment. This innovative approach targets the bone morphogenetic protein receptor type II (Bmpr2) to prevent or slow the progression of the disease.
Career Highlights
Terence M Doherty is affiliated with The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. His work focuses on developing therapeutic strategies that address complex genetic conditions, showcasing his commitment to advancing medical science.
Collaborations
Doherty collaborates with Virender Rehan, contributing to research efforts aimed at improving treatment options for patients suffering from pulmonary artery hypertension.
Conclusion
Terence M Doherty's innovative work in the field of pulmonary artery hypertension treatment exemplifies the impact of dedicated research and collaboration in advancing healthcare solutions. His contributions are vital in the ongoing fight against genetic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile